News
Rivaroxaban tablets have several indications, including reducing the risk of stroke and systemic embolism in nonvalvular ...
Lupin receives US FDA approval for rivaroxaban tablets USP, 10 mg, 15 mg & 20 mg: Our Bureau, Mumbai Thursday, May 15, 2025, 15:40 Hrs [IST] Global pharma major Lupin Limited (Lup ...
6d
Capital Market on MSNAlembic Pharma rises on USFDA approval for Rivaroxaban TabletsThe approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Xarelto Tablets, 2.5 mg, 10 mg, ...
Mumbai: Global pharma major Lupin Limited has received approval from the United States Food and Drug Administration (U.S. FDA ...
14d
MedPage Today on MSNOral Obicetrapib Takes Lipid Lowering to Another Level in TrialsObicetrapib provided dramatic reductions in LDL cholesterol, without noticeable side effects, in a phase III trial of ...
Ergot alkaloids were the first antimigraine drugs available. Dihydroergotamine (DHE) is an ergotamine analog (Figure 3). DHE is administered as a nasal spray form (Migranal®, Valeant ...
Rivaroxaban, an oral anticoagulant, helps prevent the formation of blood clots by inhibiting Factor Xa, an essential protein ...
Drugmaker Lupin has received U.S. Food and Drug Administration (U.S. FDA) approval for Rivaroxaban Tablets USP, 10 mg, 15 mg, and 20 mg, its generic version of Janssen Pharmaceuticals’ blood thinner ...
Alembic Pharmaceuticals (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Rivaroxaban Tablets ...
As ADHD and paediatric sleep disorders rise, French health authorities are calling for general practitioners to play a ...
Lisdexamfetamine Dimesylate chewable tablets are currently listed on the ... available in multiple strengths to treat ADHD including 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, and 60 mg.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results